Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2009

01.03.2009 | Breast Oncology

Patterns of Axillary Surgical Care for Breast Cancer in the Era of Sentinel Lymph Node Biopsy

verfasst von: John Rescigno, MD, Jamie C. Zampell, MD, Deborah Axelrod, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Population-based overall patterns of surgical management of the axilla in women with operable breast cancer during the era of adoption of sentinel lymph node biopsy (SLNB) were studied.

Methods

Women with operable breast carcinoma residing in 14 geographic areas of the Surveillance, Epidemiology, and End Results (SEER) cancer registries (1998–2004, n = 239,661) were assessed for axillary surgical patterns of care.

Results

Use of SLNB increased from 11 to 59%. Use of no axillary surgery decreased from 14 to 6.6%. In pathologic node-negative women, use of axillary lymph node dissection (ALND) decreased from 94 to 36%. Independent factors most associated with failure to receive SLNB included diagnosis year (2000: 62%; 2004: 29%), surgery (mastectomy: 64%; breast-conserving surgery: 36%), tumor size (T3: 71%; T2: 56%; T1: 40%), age (≥70 years: 50%; <70 years: 45%), grade (high: 42%; low: 38%), urbanity (non-large metropolitan area: 49%; large metropolitan area: 42%), and, by quartile, poverty (highest: 47%; lowest: 35%), and white-collar employment (lowest: 56%; highest: 47%). In pathologic node-positive women who had SLNB, failure to undergo completion ALND increased from 20% in 1998 to 32% in 2004. Patients with smaller, lower-grade tumors, and those with smaller size of nodal metastasis, lack of extracapsular extension, age ≥70 years, increased linguistic isolation, African-American or Hispanic race/ethnicity, and white-collar employment were less likely to undergo completion ALND.

Conclusions

Management of the axilla changed dramatically during the period of rapid adoption of SLNB. Patterns of care suggest both appropriate and inappropriate selection for SLNB and ALND.
Literatur
1.
Zurück zum Zitat Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980;45(12):2917–24.PubMedCrossRef Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980;45(12):2917–24.PubMedCrossRef
2.
Zurück zum Zitat Foster RS, Jr. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin North Am. 1996;5(1):79–104. Foster RS, Jr. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin North Am. 1996;5(1):79–104.
3.
Zurück zum Zitat Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–8; discussion 398–401.PubMedCrossRef Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–8; discussion 398–401.PubMedCrossRef
4.
Zurück zum Zitat Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335–9; discussion 340.PubMedCrossRef Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335–9; discussion 340.PubMedCrossRef
5.
Zurück zum Zitat Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599–609.PubMedCrossRef Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599–609.PubMedCrossRef
6.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–53.PubMedCrossRef Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–53.PubMedCrossRef
7.
Zurück zum Zitat Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Limited-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. Surveillance, Epidemiology, and End Results (SEER) Program (www.​seer.​cancer.​gov) Limited-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
9.
Zurück zum Zitat Zhang J, Yu KF. What’s the relative risk. A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.PubMedCrossRef Zhang J, Yu KF. What’s the relative risk. A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.PubMedCrossRef
10.
Zurück zum Zitat Keynes G. Conservative treatment of cancer of the breast. BMJ. 1937;2(4004):643–7.CrossRef Keynes G. Conservative treatment of cancer of the breast. BMJ. 1937;2(4004):643–7.CrossRef
11.
Zurück zum Zitat Baclesse F. Roentgen therapy as the sole method of treatment of cancer of the breast. Am J Roentgenol Radium Ther Nucl Med. 1949;62(3):311–9. Baclesse F. Roentgen therapy as the sole method of treatment of cancer of the breast. Am J Roentgenol Radium Ther Nucl Med. 1949;62(3):311–9.
12.
Zurück zum Zitat Peters MV. Carcinoma of the breast Stage II-radiation range Wedge resection and irradiation. An effective treatment in early breast cancer. JAMA. 1967;200(2):134–5.PubMedCrossRef Peters MV. Carcinoma of the breast Stage II-radiation range Wedge resection and irradiation. An effective treatment in early breast cancer. JAMA. 1967;200(2):134–5.PubMedCrossRef
13.
Zurück zum Zitat Levene MB, Harris JR, Hellman S. Treatment of carcinoma of the breast by radiation therapy. Cancer. 1977;39(6 Suppl):2840–5.PubMedCrossRef Levene MB, Harris JR, Hellman S. Treatment of carcinoma of the breast by radiation therapy. Cancer. 1977;39(6 Suppl):2840–5.PubMedCrossRef
14.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (EBCTG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of randomized trials. Lancet. 2005;366(9503):2087–106. Early Breast Cancer Trialists’ Collaborative Group (EBCTG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of randomized trials. Lancet. 2005;366(9503):2087–106.
15.
Zurück zum Zitat NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer. Bethesda, Maryland, June 18–21, 1990. J Natl Cancer Inst Monogr. 1992;(11):1–187. NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer. Bethesda, Maryland, June 18–21, 1990. J Natl Cancer Inst Monogr. 1992;(11):1–187.
16.
Zurück zum Zitat Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86(4):628–37.PubMedCrossRef Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86(4):628–37.PubMedCrossRef
17.
Zurück zum Zitat Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339(14):941–6.PubMedCrossRef Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339(14):941–6.PubMedCrossRef
18.
Zurück zum Zitat Fisher B. From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century. Eur J Cancer. 1999;35(14):1963–73.PubMedCrossRef Fisher B. From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century. Eur J Cancer. 1999;35(14):1963–73.PubMedCrossRef
19.
Zurück zum Zitat Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg. 1984;119(9):1067–72.PubMed Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg. 1984;119(9):1067–72.PubMed
20.
Zurück zum Zitat Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer. 2002;94(10):2542–51. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer. 2002;94(10):2542–51.
21.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7(12):983–90.PubMedCrossRef Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7(12):983–90.PubMedCrossRef
22.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel lymph node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B–32 randomised phase III trial. Lancet Oncol. 2007;8(10):881–8.PubMedCrossRef Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel lymph node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B–32 randomised phase III trial. Lancet Oncol. 2007;8(10):881–8.PubMedCrossRef
23.
Zurück zum Zitat Barone JE, Tucker JB, Perez JM, Odom SR, Ghevariya V. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg. 2005;71(1):66–70.PubMed Barone JE, Tucker JB, Perez JM, Odom SR, Ghevariya V. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg. 2005;71(1):66–70.PubMed
24.
Zurück zum Zitat Bembenek A, Fischer J, Albrecht H, et al. Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified? World J Surg. 2007;31(2):267–75.PubMedCrossRef Bembenek A, Fischer J, Albrecht H, et al. Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified? World J Surg. 2007;31(2):267–75.PubMedCrossRef
25.
Zurück zum Zitat Lelievre L, Houvenaeghel G, Buttarelli M, et al. Value of the sentinel lymph node procedure in patients with large size breast cancer. Ann Surg Oncol. 2007;14(2):621–6.PubMedCrossRef Lelievre L, Houvenaeghel G, Buttarelli M, et al. Value of the sentinel lymph node procedure in patients with large size breast cancer. Ann Surg Oncol. 2007;14(2):621–6.PubMedCrossRef
26.
Zurück zum Zitat Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20.PubMedCrossRef Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20.PubMedCrossRef
27.
Zurück zum Zitat Garreau JR, Nelson J, Cook D, et al. Geographic variation in sentinel node adaptation by practicing surgeons in Oregon. Am J Surg. 2005;189(5):616–6; discussion 619–20.PubMedCrossRef Garreau JR, Nelson J, Cook D, et al. Geographic variation in sentinel node adaptation by practicing surgeons in Oregon. Am J Surg. 2005;189(5):616–6; discussion 619–20.PubMedCrossRef
28.
Zurück zum Zitat Conn CA, McMasters KM, Edwards MJ, Martin RC. Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in Kentucky. Breast J. 2005;11(4):231–5.PubMedCrossRef Conn CA, McMasters KM, Edwards MJ, Martin RC. Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in Kentucky. Breast J. 2005;11(4):231–5.PubMedCrossRef
29.
Zurück zum Zitat Chua B, Olivotto IA, Donald JC, Hayashi AH, Davis N, Rusnak CH. Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia. Can J Surg. 2003;46(4):273–8.PubMed Chua B, Olivotto IA, Donald JC, Hayashi AH, Davis N, Rusnak CH. Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia. Can J Surg. 2003;46(4):273–8.PubMed
30.
Zurück zum Zitat Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients. J Natl Cancer Inst. 2008;100(7):462–74.PubMedCrossRef Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients. J Natl Cancer Inst. 2008;100(7):462–74.PubMedCrossRef
31.
Zurück zum Zitat Wong JS, Taghian AG, Bellon JR, et al. Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial. Int J Radiat Oncol Biol Phys. 2008; in press. Wong JS, Taghian AG, Bellon JR, et al. Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial. Int J Radiat Oncol Biol Phys. 2008; in press.
32.
Zurück zum Zitat Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51(3):671–8.PubMed Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51(3):671–8.PubMed
33.
Zurück zum Zitat Park J, Fey JV, Naik AM, Borgen PI, Van Zee KJ, Cody HS 3rd. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg. 2007;245(3):462–8.PubMedCrossRef Park J, Fey JV, Naik AM, Borgen PI, Van Zee KJ, Cody HS 3rd. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg. 2007;245(3):462–8.PubMedCrossRef
34.
Zurück zum Zitat Hwang RF, Gonzalez-Angulo AM, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110:723–30.PubMedCrossRef Hwang RF, Gonzalez-Angulo AM, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110:723–30.PubMedCrossRef
35.
Zurück zum Zitat Rescigno J, Taylor LA, Aziz MS, et al. Predicting negative axillary lymph node dissection in patients with positive sentinel lymph node biopsy: can a subset of patients be spared axillary dissection? Breast Cancer Res Treat. 2005;94(Supp 1):S35–6. Rescigno J, Taylor LA, Aziz MS, et al. Predicting negative axillary lymph node dissection in patients with positive sentinel lymph node biopsy: can a subset of patients be spared axillary dissection? Breast Cancer Res Treat. 2005;94(Supp 1):S35–6.
36.
Zurück zum Zitat Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005;190:543–50.PubMedCrossRef Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005;190:543–50.PubMedCrossRef
37.
Zurück zum Zitat Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–7.PubMedCrossRef Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–7.PubMedCrossRef
38.
Zurück zum Zitat Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol. 2005;16(3):383–8.PubMedCrossRef Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol. 2005;16(3):383–8.PubMedCrossRef
Metadaten
Titel
Patterns of Axillary Surgical Care for Breast Cancer in the Era of Sentinel Lymph Node Biopsy
verfasst von
John Rescigno, MD
Jamie C. Zampell, MD
Deborah Axelrod, MD
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 3/2009
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0195-5

Weitere Artikel der Ausgabe 3/2009

Annals of Surgical Oncology 3/2009 Zur Ausgabe

Chirurginnen nehmen sich Zwischenfälle im OP besonders zu Herzen

05.06.2024 Allgemeine Chirurgie Nachrichten

Selbstverschuldete Fehler oder unerwartete Komplikationen machen jungen Chirurginnen und Operateuren mit Migrationshintergrund offenbar besonders zu schaffen. Benötigt werden routinemäßige Programme zum Umgang mit Zwischenfällen im OP.

Schützt auch die medikamentöse Gewichtsreduktion vor Krebs?

03.06.2024 ASCO 2024 Kongressbericht

Offenbar muss es nicht immer die bariatrische Chirurgie sein, wenn es darum geht, durch deutlichen Gewichtsverlust auch das Krebsrisiko günstig zu beeinflussen. Eine große Kohortenanalyse zur Behandlung mit GLP-1-Agonisten wurde dazu auf der ASCO-Tagung vorgestellt.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.